Tramadol + PDE5 Inhibitor (Aytu BioScience/Daewoong)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTramadol + PDE5 Inhibitor (Aytu BioScience/Daewoong)
Drug Alias NameTramadol + PDE5 Inhibitor (Vyrix Therapeutics/Daewoong)Tramadol + PDE5 Inhibitor (Ampio Pharmaceuticals/Daewoong)Zertane-ED
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsPhosphodiesterase 5A inhibitorsSerotonin reuptake inhibitors
TargetsMu opioid receptorPhosphodiesterase 5ASerotonin transporter
Therapy Area/IndicationsPremature EjaculationErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsYes
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmpio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVyrix Pharmaceuticals IncAmpio Pharmaceuticals IncDaewoong Pharmaceutical Co Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsPremature EjaculationErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A